Medical cannabis

Columbia Care Launches First of Its Kind Medical Cannabis Capsule in UK; Provides More Precise Dosing Option and Longer Lasting Therapeutic Benefits for Physicians and Patients

Biotechnology, Pharmaceutical, Health, Herbalism, Medicinal plants, Health sciences, Health, Drug control law, Antioxidants, Medical cannabis, Legality of cannabis, Cannabis, Dose
Thursday, April 15, 2021 - 8:00am

This is the first solid-fill capsule of its kind available in the UK and the first dose-metered medicinal cannabis product to be manufactured in the UK.

Key Points: 
  • This is the first solid-fill capsule of its kind available in the UK and the first dose-metered medicinal cannabis product to be manufactured in the UK.
  • These dosing options enable prescribing physicians to offer proven, cannabis-based medical solutions with a degree of precision previously unavailable in the UK market.
  • We believe this has the potential to truly drive normalization around cannabis use for physicians and patients alike,\xe2\x80\x9d said Rosemary Mazanet, M.D./Ph.D., Chief Scientific Officer, Columbia Care.
  • Not only are most patients familiar with a capsule, but many will also see other benefits of this formulation.

Pamos, a California-Born Cannabis Spirit, Launches in Los Angeles

Food, Beverage, Wine & Spirits, Retail, Tobacco, Specialty, Euphoriants, Entheogens, Psychoactive drugs, Medicinal plants, Cannabis smoking, Drugs, Appetite stimulants, Branches of biology, Cannabis, Tetrahydrocannabinol, Effects of cannabis, Medical cannabis
Tuesday, April 13, 2021 - 2:00pm

Pamos is a premium quality, non-alcoholic cannabis spirit infused with THC, CBD, and plant terpenes and is now available for pre-orders at www.pamos.com in Los Angeles.

Key Points: 
  • Pamos is a premium quality, non-alcoholic cannabis spirit infused with THC, CBD, and plant terpenes and is now available for pre-orders at www.pamos.com in Los Angeles.
  • With the belief that a good time shouldn\xe2\x80\x99t be a gamble, Pamos speaks to conscious consumers who want to satisfy their social needs without sacrificing their wellness goals.
  • The THC in the Pamos spirits provides a sense of calm, while the CBD is included to relax one\xe2\x80\x99s body.
  • Pamos can be enjoyed on the rocks or you can tap into your inner mixologist to make it your own.

Clear Cannabis Inc. Announces Partnership with Trucenta to Bring The Clear Back to Michigan Market

Other Health, MEN, General Health, Tobacco, Specialty, Consumer, Agriculture, Natural Resources, Retail, Women, Alternative medicine, Health, Medicinal plants, Entheogens, Euphoriants, Herbalism, Health sciences, Branches of biology, Cannabis, Cannabis smoking, Medical cannabis, Pharmaceutical sciences
Tuesday, April 13, 2021 - 1:06pm

b'Clear Cannabis Inc. (CCI), master licensor of legacy cannabis concentrates brand The Clear\xe2\x84\xa2 , has announced a partnership with the vertically-integrated cannabis company Trucenta to bring The Clear brand to Michigan.

Key Points: 
  • b'Clear Cannabis Inc. (CCI), master licensor of legacy cannabis concentrates brand The Clear\xe2\x84\xa2 , has announced a partnership with the vertically-integrated cannabis company Trucenta to bring The Clear brand to Michigan.
  • \xe2\x80\x9cWe finally found the perfect partner to provide the quality and consistency that Michigan consumers deserve.
  • Keep an eye on The Clear website and your favorite dispensaries for launch availability.\nFor information on where to find The Clear, visit: www.clearconcentrate.com\nClear Cannabis, Inc. is a national cannabis brand company and licensor of The Clear\xe2\x84\xa2.
  • Established in 2013, The Clear THC products are available in multiple cannabis markets in the U.S., with CBD products distributed internationally.

QwikLeaf Unveils World's First Cannabis Smart Locker and Delivery Network

Cannabis smoking, Herbalism, Medicinal plants, Psychoactive drugs, Cannabis, Health sciences, Entheogens, Effects of cannabis, Medical cannabis, Draft:Verda, Cannabis in Australia
Thursday, April 15, 2021 - 3:17pm

b'PALM SPRINGS, Calif., April 15, 2021 /PRNewswire/ --QwikLeaf, developer of the world\'s first smart locker solution for cannabis deliveries, today announced the completion of its technology platform.

Key Points: 
  • b'PALM SPRINGS, Calif., April 15, 2021 /PRNewswire/ --QwikLeaf, developer of the world\'s first smart locker solution for cannabis deliveries, today announced the completion of its technology platform.
  • The platform allows for cannabis customers to order online and pick-up orders from a locker location of their choice.\n"In the fastest growing industry in the world, QwikLeaf is deploying the first network of cannabis delivery pick-up locations for cannabis," said Neil Biafore, CEO and Founder at QwikLeaf.
  • "We have spent years building the first smart locker platform for ordering cannabis and now is the time to take QwikLeaf to the public.
  • This is a once in a lifetime opportunity to deploy the world\'s first network of smart lockers dedicated to cannabis sales"\nQwikLeaf\'s ground-breaking, user-centric platform makes buying cannabis online fast, safe, and as easy as in any other industry, offering customers in particular an alternative to ordering at dispensaries.\nQwikLeaf is set to install 75 smart lockers for cannabis delivery throughout Los Angeles, California starting mid-summer 2021.\nBased in Palm Springs, CA, QwikLeaf is the cannabis industry\'s leading and fastest-growing cannabis delivery technology company.

Improving Quality of THC-Based Medications Proving to be Lucrative Path for Cannabis Companies

Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Appetite stimulants, Antiemetics, Drugs, Branches of biology, Cannabis, Medical cannabis, Tetrahydrocannabinol, Effects of cannabis
Thursday, April 15, 2021 - 2:20pm

"The increasing awareness among patients as well as healthcare professionals regarding the benefits of medical marijuana has compelled the regulatory authorities to consider and legalize medical cannabis.

Key Points: 
  • "The increasing awareness among patients as well as healthcare professionals regarding the benefits of medical marijuana has compelled the regulatory authorities to consider and legalize medical cannabis.
  • THC-based medications are also noted to act as appetite stimulators in cases with wasting syndrome caused owing to AIDS.
  • All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Improving Quality of THC-Based Medications Proving to be Lucrative Path for Cannabis Companies

Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Appetite stimulants, Antiemetics, Drugs, Branches of biology, Cannabis, Medical cannabis, Tetrahydrocannabinol, Effects of cannabis
Thursday, April 15, 2021 - 2:20pm

"The increasing awareness among patients as well as healthcare professionals regarding the benefits of medical marijuana has compelled the regulatory authorities to consider and legalize medical cannabis.

Key Points: 
  • "The increasing awareness among patients as well as healthcare professionals regarding the benefits of medical marijuana has compelled the regulatory authorities to consider and legalize medical cannabis.
  • THC-based medications are also noted to act as appetite stimulators in cases with wasting syndrome caused owing to AIDS.
  • All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.
  • You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements.

Law Enforcement Concerns Arise Amidst Sweeping Cannabis Legalization

Herbalism, Medicinal plants, Health sciences, Aurora Cannabis, Cannabis in Alberta, Medicine, Cannabis, Tilray, Branches of biology, Medical cannabis
Thursday, April 15, 2021 - 2:00pm

A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.

Key Points: 
  • A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.
  • Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Planet 13 Holdings Inc. (OTC: PLNHF), Aurora Cannabis Inc. (NYSE: ACB), Tilray, Inc. (NASDAQ: TLRY), HEXO Corp. (NYSE: HEXO)\nHowever, the growing popularity of cannabis raises some regulation concerns.
  • In fact, one of the major concerns over cannabis abuse revolves around operating a vehicle while impaired.
  • Generally, law enforcement officers may conduct field tests such as sobriety tests or even sample tests.

Law Enforcement Concerns Arise Amidst Sweeping Cannabis Legalization

Herbalism, Medicinal plants, Health sciences, Aurora Cannabis, Cannabis in Alberta, Medicine, Cannabis, Tilray, Branches of biology, Medical cannabis
Thursday, April 15, 2021 - 2:00pm

A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.

Key Points: 
  • A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.
  • Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Planet 13 Holdings Inc. (OTC: PLNHF), Aurora Cannabis Inc. (NYSE: ACB), Tilray, Inc. (NASDAQ: TLRY), HEXO Corp. (NYSE: HEXO)\nHowever, the growing popularity of cannabis raises some regulation concerns.
  • In fact, one of the major concerns over cannabis abuse revolves around operating a vehicle while impaired.
  • Generally, law enforcement officers may conduct field tests such as sobriety tests or even sample tests.

How Growing Number Of Clinical Trials Are Influencing Growth Of The Cannabis Pharmaceuticals

Cannabis, Drugs, Psychoactive drugs, Medicinal plants, Entheogens, Euphoriants, Herbalism, Cannabis smoking, Cannabidiol, Medical cannabis, Effects of cannabis, Cannabinoid Research Initiative of Saskatchewan
Wednesday, April 14, 2021 - 2:30pm

The clinical trials and approval of some cannabis-infused products have opened up the market for cannabinoid-based pharmaceuticals.

Key Points: 
  • The clinical trials and approval of some cannabis-infused products have opened up the market for cannabinoid-based pharmaceuticals.
  • This concept revolves around a shift from the traditional approach of smoking whole cannabis flower/bud to the consumption of processed, quantified, and packaged products derived from cannabis."
  • Furthermore, it will also help companies to conduct clinical studies to broaden the application areas.
  • The growing number of clinical trials for various health conditions, due to the therapeutic properties of cannabis especially Cannabidiol (CBD) is also influencing the growth of the market The surge in the number of authorizing physicians providing medical cannabis to patients owing to an increase in clinical evidence, rise in the awareness, comfort with the process, and the growing number of patients looking for medical cannabis as a potential alternative to traditional drugs is likely to drive the demand worldwide.

How Growing Number Of Clinical Trials Are Influencing Growth Of The Cannabis Pharmaceuticals

Cannabis, Drugs, Psychoactive drugs, Medicinal plants, Entheogens, Euphoriants, Herbalism, Cannabis smoking, Cannabidiol, Medical cannabis, Effects of cannabis, Cannabinoid Research Initiative of Saskatchewan
Wednesday, April 14, 2021 - 2:30pm

The clinical trials and approval of some cannabis-infused products have opened up the market for cannabinoid-based pharmaceuticals.

Key Points: 
  • The clinical trials and approval of some cannabis-infused products have opened up the market for cannabinoid-based pharmaceuticals.
  • This concept revolves around a shift from the traditional approach of smoking whole cannabis flower/bud to the consumption of processed, quantified, and packaged products derived from cannabis."
  • Furthermore, it will also help companies to conduct clinical studies to broaden the application areas.
  • The growing number of clinical trials for various health conditions, due to the therapeutic properties of cannabis especially Cannabidiol (CBD) is also influencing the growth of the market The surge in the number of authorizing physicians providing medical cannabis to patients owing to an increase in clinical evidence, rise in the awareness, comfort with the process, and the growing number of patients looking for medical cannabis as a potential alternative to traditional drugs is likely to drive the demand worldwide.